Literature DB >> 19782388

Lupus Anticoagulant (LAC) testing in patients with inflammatory status: does C-reactive protein interfere with LAC test results?

Sofie M E Schouwers, Joris R Delanghe, Katrien M J Devreese.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19782388     DOI: 10.1016/j.thromres.2009.09.001

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  26 in total

Review 1.  In Utero Aortic Arch Thrombosis Masquerading as Interrupted Aortic Arch: A Case Report and Review of the Literature.

Authors:  Joseph J Knadler; Mark Zobeck; Prakash Masand; Sarah Sartain; William B Kyle
Journal:  Pediatr Cardiol       Date:  2019-02-08       Impact factor: 1.655

Review 2.  Antiphospholipid syndrome: Complement activation, complement gene mutations, and therapeutic implications.

Authors:  Shruti Chaturvedi; Evan M Braunstein; Robert A Brodsky
Journal:  J Thromb Haemost       Date:  2021-02-10       Impact factor: 5.824

Review 3.  Laboratory Diagnosis of Antiphospholipid Syndrome: Insights and Hindrances.

Authors:  Arne Vandevelde; Katrien M J Devreese
Journal:  J Clin Med       Date:  2022-04-13       Impact factor: 4.964

Review 4.  The Role of Autoantibody Testing in Modern Personalized Medicine.

Authors:  Cristiane Kayser; Lívia Almeida Dutra; Edgard Torres Dos Reis-Neto; Charlles Heldan de Moura Castro; Marvin J Fritzler; Luis Eduardo C Andrade
Journal:  Clin Rev Allergy Immunol       Date:  2022-03-04       Impact factor: 10.817

5.  A Review of Pathophysiology, Clinical Features, and Management Options of COVID-19 Associated Coagulopathy.

Authors:  Julie Goswami; Taleen A MacArthur; Meera Sridharan; Rajiv K Pruthi; Robert D McBane; Thomas E Witzig; Myung S Park
Journal:  Shock       Date:  2021-06-01       Impact factor: 3.533

Review 6.  Antiphospholipid antibodies in critically ill COVID-19 patients with thromboembolism: cause of disease or epiphenomenon?

Authors:  Vittorio Pavoni; Lara Gianesello; Andrew Horton
Journal:  J Thromb Thrombolysis       Date:  2021-05-10       Impact factor: 2.300

7.  Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?

Authors:  Thomas Foret; Virginie Dufrost; Lucie Salomon Du Mont; Patricia Costa; Benjamin Lefevre; Patrick Lacolley; Veronique Regnault; Stephane Zuily; Denis Wahl
Journal:  Curr Rheumatol Rep       Date:  2021-07-03       Impact factor: 4.592

Review 8.  Neurologic Manifestations of the Antiphospholipid Syndrome - an Update.

Authors:  Miguel Leal Rato; Matilde Bandeira; Vasco C Romão; Diana Aguiar de Sousa
Journal:  Curr Neurol Neurosci Rep       Date:  2021-06-14       Impact factor: 5.081

9.  Coagulopathy of COVID-19 and antiphospholipid antibodies.

Authors:  Nathan T Connell; Elisabeth M Battinelli; Jean M Connors
Journal:  J Thromb Haemost       Date:  2020-05-07       Impact factor: 5.824

10.  Antiphospholipid antibodies in patients with COVID-19: A relevant observation?

Authors:  Katrien M J Devreese; Eleni A Linskens; Dominique Benoit; Harlinde Peperstraete
Journal:  J Thromb Haemost       Date:  2020-07-23       Impact factor: 16.036

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.